Cambridge, Mass.-based Idera Pharmaceuticals and Bermuda-based Vivelix Pharmaceuticals entered into an exclusive license and collaboration agreement giving Vivelix the rights to develop and market IMO-9200, an antagonist of TLR 7,8 and 9, for non-malignant gastrointestinal disorders.
GI & Endoscopy
Michael Gilbert Goggins, MD, is a gastroenterologist and a professor of pathology, medicine and oncology at Baltimore's John Hopkins Medicine.
Genetic Technologies and Australia-based University of Melbourne have entered a license agreement to develop a new colorectal cancer risk assessment test.
A study in the American Journal of Gastroenterology investigated whether offering small financial incentives to patients increases colorectal cancer screening compliance.
Carl Gessner, MD, is a gastroenterologist at Greensboro, N.C.-based LeBauer HealthCare.
Advertisement
Future Market Insights believes the video endoscopy market is poised for growth, according to a new report.
Here are eight gastroenterologists in the news this past week.
Peter Kaye, MD, is a gastroenterologist at Boulder, Colo.-based Gastroenterology of the Rockies.
Neil Gupta, MD, wrote an article in Gastroenterology featuring four ways to improve your adenoma detection rate.
Here are the five most popular Becker's ASC Review gastroenterology and endoscopy stories for the week of Nov. 21 to Nov. 25, 2016.